Codexis (CDXS) Receivables - Other (2010 - 2026)
Codexis' (CDXS) quarterly Receivables - Other came in at $1.3 million in Q1 2026, down 66.41% year-on-year from $3.8 million in Q1 2025, and down 12.64% quarter-over-quarter from $1.5 million in Q4 2025.
Codexis (CDXS) Receivables - Other (2010 - 2026) Analysis & Trends
Codexis' Receivables - Other history runs 15 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Receivables - Other fell 66.41% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 66.41% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 45.73% from the prior year.
- Receivables - Other slipped to $1.3 million in Q1 2026 per CDXS's latest filing, from $1.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $10.7 million in Q2 2023 and bottomed at $1.3 million in Q1 2026.
- The 5-year median for Receivables - Other is $5.7 million (2023), against an average of $5.7 million.
- Across the five-year window, Receivables - Other jumped 30.3% in 2023 and sank 69.91% in 2024, its largest moves.
- Year by year, Receivables - Other stood at $7.0 million in 2022, then jumped by 30.3% to $9.1 million in 2023, then sank by 69.91% to $2.8 million in 2024, then sank by 46.2% to $1.5 million in 2025, then fell by 12.64% to $1.3 million in 2026.
- Per Business Quant, the three latest CDXS Receivables - Other figures stand at $1.3 million (Q1 2026), $1.5 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 9.14 Mn |
| Dec 31, 2023 | 9.14 Mn |